Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: A Phase 1 Study of Reolysin Alone in Patients With Relapsed or Refractory Multiple Myeloma
Brief Summary: This pilot phase I trial studies the side effects and the best dose of giving viral therapy to patients with relapsed or refractory multiple myeloma. Viral therapy, such as wild-type reovirus, may be able to kill cancer cells without damaging normal cells.